SCHEMBL8526464

SCHEMBL8526464

O=C1Nc2ccc(CO)cc2C1=Cc1ccc2ccccc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.56
ALDH1A1 P00352 1/20 0.56
GAA P10253 1/20 0.56
MAPT P10636 1/20 0.56
LRRK2 Q5S007 4/20 0.48
PLK4 O00444 3/20 0.47
PLK1 P53350 2/20 0.47
PDGFRB P09619 2/20 0.47
RET P07949 1/20 0.47
FLT3 P36888 1/20 0.47
PSEN1 P49768 1/20 0.46
PSEN2 P49810 1/20 0.46
APH1B Q8WW43 1/20 0.46
NCSTN Q92542 1/20 0.46
APH1A Q96BI3 1/20 0.46
PSENEN Q9NZ42 1/20 0.46
PDPK1 O15530 1/20 0.46
EGFR P00533 1/20 0.44
ERBB2 P04626 1/20 0.44
IGF1R P08069 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8526924 0.88 PDPK1 (0.60) KDM4EALDH1A1GAAMAPTLRRK2
SCHEMBL5474945 0.82 MAPT (0.68) KDM4EALDH1A1GAAMAPTPLK4
SCHEMBL5474941 0.82 MAPT (0.68) KDM4EALDH1A1GAAMAPTPLK4
SCHEMBL5472246 0.81 LRRK2 (0.73) KDM4EALDH1A1GAAMAPTLRRK2
SCHEMBL5472244 0.81 LRRK2 (0.73) KDM4EALDH1A1GAAMAPTLRRK2
SCHEMBL8528685 0.81 KDM4E (0.50) KDM4EALDH1A1GAAMAPTLRRK2
SCHEMBL8527809 0.80 KDM4E (0.54) KDM4EALDH1A1GAAMAPTLRRK2
SCHEMBL8530317 0.78 MAPT (0.47) KDM4EALDH1A1GAAMAPTLRRK2
SCHEMBL8529701 0.78 KDM4E (0.47) KDM4EALDH1A1GAAMAPTLRRK2
Hydrochloric Acid SCHEMBL8526637 0.78 KDM4E (0.52) KDM4EALDH1A1GAAMAPTLRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5840745-A INHIBITING CELL PROLIFERATION, TUMOR GROWTH, METASTASIS, DEVELOPMENT OF ATHEROMATOUS PLAQUE AND RESTENOSIS, CONTROLLING ANGIOGENESIS, TREATING DIABETES, ENHANCING CANCER THERAPY PHARMACIA S. P. A. (IT) 1998-11-24 US claimed
EP-0752985-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA & UPJOHN S.p.A. (IT) 1997-01-15 EP claimed
WO-1996022976-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA S.P.A. (IT) 1996-08-01 WO claimed
US-5840745-A INHIBITING CELL PROLIFERATION, TUMOR GROWTH, METASTASIS, DEVELOPMENT OF ATHEROMATOUS PLAQUE AND RESTENOSIS, CONTROLLING ANGIOGENESIS, TREATING DIABETES, ENHANCING CANCER THERAPY PHARMACIA S. P. A. (IT) 1998-11-24 US disclosed
EP-0752985-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA & UPJOHN S.p.A. (IT) 1997-01-15 EP disclosed
WO-1996022976-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA S.P.A. (IT) 1996-08-01 WO disclosed